TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær Jørgensen, Christina Annette Bjerre, Bent Laursen Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte L. Nielsen

    6 Citationer (Scopus)
    784 Downloads (Pure)

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group'. Sammen danner de et unikt fingeraftryk.

    Medicin og biovidenskab